Publication

Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses

See how young and geriatric horses show similar phenylbutazone PK profiles, indicating no dose adjustment…

CertaraJune 28, 2024

Publication

Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients

Learn how lorazepam and valproate significantly affect ziprasidone clearance; PopPK modelling supports personalized dosing using…

CertaraJune 25, 2024

Publication

Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.

Find out how gestational and postnatal age drive fluconazole PK variability; PopPK modelling supports tailored…

CertaraJune 8, 2024

Case Study

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Discover how Certara's Phoenix Hosted streamlined data compliance and management for a biotech company, enhancing…

CertaraMay 31, 2024

Publication

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Explore how nifedipine CR formulations are bioequivalent; food reduces exposure modestly, analysed using Phoenix WinNonlin.

CertaraMarch 13, 2024

Publication

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

Discover how PopPK modelling supports dose‑adjustment considerations for ORIN1001 based on bilirubin and lean body…

CertaraMarch 4, 2024

On-Demand Webinar

What is new in Phoenix 8.5?

Discover the latest advancements and enhancements in Phoenix version 8.5. Watch the webinar to learn…

CertaraFebruary 26, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

Blog

Dose optimization considerations for targeted radiation therapies

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…

CertaraFebruary 16, 2024

Publication

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

See how DRG‑based PK‑TD modelling predicts neuropathy severity and supports safer oxaliplatin dosing strategies using…

CertaraFebruary 1, 2024

Modeling and Simulation

Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses

Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients

Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.

Streamlining Biotech Data Compliance and Management with Certara’s Phoenix® Cloud

Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults

Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors

What is new in Phoenix 8.5?

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Dose optimization considerations for targeted radiation therapies

Pharmacokinetic – toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin – induced Peripheral Neurpathu

Newsletter sign up

Quick links

Solutions

Contact